Holen Sie sich die Stockscreener-App
365.74
0.20%
0.74
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt WST?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$365.00
Offen:
$366.08
24-Stunden-Volumen:
546.89K
Relative Volume:
0.64
Marktkapitalisierung:
$25.84B
Einnahmen:
$3.22B
Nettoeinkommen (Verlust:
$542.70M
KGV:
48.89
EPS:
7.4805
Netto-Cashflow:
$458.00M
1W Leistung:
+5.53%
1M Leistung:
+17.16%
6M Leistung:
+32.32%
1J Leistung:
+65.33%
1-Tages-Spanne:
$362.83
$367.66
1-Wochen-Bereich:
$342.70
$367.66
52-Wochen-Spanne:
$206.80
$367.66
West Pharmaceutical Services Inc Stock (WST) Company Profile
Firmenname
West Pharmaceutical Services Inc
Sektor
Telefon
(610) 594-2900
Adresse
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST vs ISRG, BDX, MDLN, ALC, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
365.74 | 25.36B | 3.22B | 542.70M | 458.00M | 7.4805 |
ISRG
Intuitive Surgical Inc
|
426.01 | 140.84B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
158.08 | 41.70B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
43.19 | 33.35B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
69.66 | 32.72B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
209.63 | 28.27B | 5.54B | 1.52B | 1.74B | 10.37 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-02 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2025-09-15 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-06-24 | Eingeleitet | Barclays | Equal Weight |
| 2025-03-18 | Eingeleitet | Evercore ISI | Outperform |
| 2025-02-14 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-01-08 | Eingeleitet | Citigroup | Buy |
| 2024-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-12-12 | Hochstufung | UBS | Neutral → Buy |
| 2024-02-07 | Hochstufung | Jefferies | Hold → Buy |
| 2023-06-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-04-11 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-11-30 | Eingeleitet | UBS | Neutral |
| 2022-10-28 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | Eingeleitet | Stephens | Equal-Weight |
| 2020-07-21 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-04-24 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | Herabstufung | Jefferies | Buy → Hold |
| 2019-04-23 | Eingeleitet | William Blair | Outperform |
| 2018-04-25 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | Eingeleitet | Goldman | Neutral |
| 2017-10-17 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | Eingeleitet | Stephens | Equal-Weight |
| 2017-09-15 | Hochstufung | Jefferies | Hold → Buy |
| 2016-10-28 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | Eingeleitet | Wells Fargo | Outperform |
| 2010-05-14 | Bestätigt | UBS | Neutral |
| 2010-02-23 | Eingeleitet | Jefferies & Co | Buy |
| 2008-12-19 | Eingeleitet | UBS | Neutral |
Alle ansehen
West Pharmaceutical Services Inc Aktie (WST) Neueste Nachrichten
KeyBanc Adjusts PT on West Pharmaceutical Services to $390 From $350, Maintains Overweight Rating - marketscreener.com
West Pharmaceutical completes sale of SmartDose 3.5mL system By Investing.com - Investing.com Australia
Form 4 West Pharmaceutical Services Inc For: 1 July By Investing.com - Investing.com Canada
West Pharmaceutical (WST) director awarded new phantom stock units and RSUs - Stock Titan
West Pharmaceutical completes sale of SmartDose 3.5mL system - Investing.com
West Completes Sale and Transfer of the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System - PR Newswire
West Pharmaceutical Services stock hits 52-week high at 363.38 USD - Investing.com
Westar™ RS LyoVials from West Pharmaceuticalmodular containment for complex injectables - AD HOC NEWS
West Pharmaceutical Services (WST) Is Up 6.7% After 21% Revenue Jump On Injectable DemandHas The Bull Case Changed? - Yahoo Finance
West Pharmaceutical Services, Inc.'s stock price skyrockets to $359.00, boasting a promising 1.22% increase - Smartkarma
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
Here's Why You Should Add BrightSpring Stock to Your Portfolio Now - TradingView
The SmartDose Gen. II injector from West Pharmaceutical Services Inc.wearable biologics delivery - AD HOC NEWS
West Pharmaceutical Services Inc. stock rises Monday, still underperforms market - MarketWatch
West Pharmaceutical focuses on long term growth, shares steady in S&P 500 healthcare segment - AD HOC NEWS
West Pharmaceutical Services (WST) Stock Analysis: Strong Revenue Growth and Bullish Analyst Ratings Offer Promising Prospects - DirectorsTalk Interviews
West Pharmaceutical Services Inc. (WST) Edges Higher as It Holds Above Key SupportBear Pennant - dars.gov.et
West Pharmaceutical Services earnings date approaches, shares backed by analyst interest - AD HOC NEWS
WST DEADLINE: ROSEN, A LEADING AND RANKED FIRM, Encourages West Pharmaceutical Services, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 7 Deadline in Securities Class ActionWST - TMX Newsfile
West Pharmaceutical Services names Michel Lagarde as next CEO, effective Aug. 31 - MSN
Lost Money on West Pharmaceutical Services, Inc. (WST)? Urged to - The National Law Review
Class Action Lawsuit Filed: West Pharmaceutical Services, Inc. (WST) – Join by July 7, 2025Contact Levi & Korsinsky - The National Law Review
West Pharmaceutical steady on Friday, S&P 500 peer group shows mixed moves - AD HOC NEWS
Price to earnings forward of West Pharmaceutical Services, Inc. – NYSE:WST - TradingView
Is West Pharmaceutical stock outperforming the S&P 500? - MSN
Vest S&P 500 Dividend Aristocrats Target Income Fund's West Pharmaceutical Services Inc(WST) Holding History - GuruFocus
West Pharmaceutical adjusts guidance on GLP-1 demand, shares extend 30-day gain - AD HOC NEWS
Westar RS Lined Seal from West Pharmaceutical Services Inc.ready-for-use vial closure targets con - Ad-hoc-news.de
West Pharmaceutical Services, Inc. Actuals & Estimates (NYSE:WST) - TradingView
West Pharmaceutical Services Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
WST Forecast — Price Target — Prediction for 2027 - TradingView
West Pharmaceutical Services Inc (WST) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
West Pharmaceutical Services Inc (WST)'s Winning Formula: Financ - GuruFocus
West Pharmaceutical Services stock hits 52-week high at $338.73 - Investing.com
West Pharmaceutical Services stock hits 52-week high at $338.73 By Investing.com - Investing.com Australia
West Pharmaceutical Services, Inc. (WST) hit a 52 week high, can the run continue? - MSN
The SmartDose 10 mL system from West Pharmaceutical Services Inc.large-volume self-injection with - Ad-hoc-news.de
WST Stock Price and Chart — NYSE:WST - TradingView
West Pharmaceutical Services Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
West Pharmaceutical opens the week with clear analyst consensus, shares hold near recent highs - Ad-hoc-news.de
Revvity Launches Signals AI to Advance Scientific R&D Workflows - TradingView
Is West Pharmaceutical Services (WST) Pricey As GLP 1 Demand Lifts Expectations? - Sahm
The NovaPure Plunger from West Pharmaceuticaltight particle specs for sensitive biologics - AD HOC NEWS
West Pharmaceutical StockSunday background on valuation and growth drivers - AD HOC NEWS
West Pharmaceutical Services (WST) Stock Could Be 6.9% Undervalued on GLP 1 Growth Narrative - Yahoo Finance
Why West Pharmaceutical’s NovaGuard SA Pro quietly matters for everyday injections - AD HOC NEWS
CAH Stock Up Nearly 8% YTD: Will the Uptrend Continue in the Rest of 2026? - TradingView
COR Stock Down Nearly 18% YTD: Should You Buy, Hold or Sell? - TradingView
West Pharmaceutical Services Inc (WST) Valuation: PE, PB & Fair Value Analysis - TradingKey
Cencora Launches Enhanced Nucleus Solution for Specialty Practices - TradingView
West Pharmaceutical stock under pressure after weekly high as technicals suggest range trading ahead - Traders Union
Finanzdaten der West Pharmaceutical Services Inc-Aktie (WST)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.24%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):